Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 11—November 2023
Research

Global Phylogeography and Genomic Epidemiology of Carbapenem-Resistant blaOXA-232–Carrying Klebsiella pneumoniae Sequence Type 15 Lineage

Yuye Wu, Tian Jiang, Xianhong He, Jiayu Shao, Chenghao Wu, Weifang Mao, Huiqiong Jia, Fang He, Yingying Kong, Jianyong Wu, Qingyang Sun, Long Sun, Mohamed S. Draz, Xinyou XieComments to Author , Jun ZhangComments to Author , and Zhi RuanComments to Author 
Author affiliations: Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou, China (Y. Wu, T. Jiang, X. He, J. Shao, C. Wu, W. Mao, Y. Kong, X. Xie, J. Zhang, Z. Ruan); Wenzhou Medical University Affiliated Wenling Hospital, Taizhou, China (T. Jiang); Third People's Hospital of Xiaoshan District, Hangzhou (X. He, J. Shao); Shaoxing University Affiliated Hospital, Shaoxing, China (W. Mao); Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou (H. Jia); Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Hangzhou (H. Jia); Zhejiang Provincial People's Hospital, Hangzhou (F. He); Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Hangzhou (Y. Kong, X. Xie, J. Zhang, Z. Ruan); Zhejiang University School of Medicine Fourth Affiliated Hospital, Hangzhou (J. Wu); No. 903 Hospital of PLA Joint Logistic Support Force, Hangzhou (Q. Sun); Hangzhou Women's Hospital, Hangzhou (L. Sun); Case Western Reserve University School of Medicine, Cleveland, Ohio, USA (M.S. Draz); Cleveland Clinic, Cleveland (M.S. Draz)

Main Article

Table 1

Characteristics of 21 infected patients in China investigated in study of global phylogeography and genomic epidemiology of blaOXA-232–carrying carbapenem-resistant Klebsiella pneumoniae sequence type 15

Isolate Age, y/sex Clinical diagnosis Specimen source Isolation date
KP3 78/M Atrial fibrillation, severe pneumonia, respiratory failure Urine 2020 Nov
KP41 66/M Cardiac failure, respiratory failure, urinary tract infection Urine 2020 Nov
KP105 61/F Cholangiolithiasis Bile 2020 Nov
KP232 86/M Cholangiolithiasis Urine 2020 Dec
KP306 42/M Severe acute pancreatitis Excreta 2020 Dec
KP5 61/M Hydrocephalus Urine 2021 Jan
KP441 76/F Lung infection, heart failure Sputum 2021 Jun
KP68 84/F Chronic obstructive pulmonary disease Bronchoalveolar lavage fluid 2021 Sep
KP76 47/F Posttraumatic brain syndrome Blood 2021 Sep
KP77 73/M Multiple brain contusion and laceration Sputum 2021 Sep
KP79 54/M Chronic obstructive pulmonary disease Sputum 2021 Sep
KP81 94/M Cerebral infarction, hypertension Sputum 2020 Aug
KP85 56/M Inhalation lung injury Sputum 2021 Oct
KP89 56/M Inhalation lung injury, respiratory failure Excreta 2021 Nov
KP91 68/M Respiratory failure, diabetes Urine 2020 Dec
KP97 55/F Exogenous injury, motor neuron disease, respiratory failure Sputum 2021 Dec
KP9112 86/F Chronic obstructive pulmonary disease Sputum 2020 Sep
KP135 76/M Cervical spinal fractures, high paraplegia Sputum 2021 Jan
KP8474 49/M Intracranial space occupying lesions Sputum 2020 Jul
KP12339 65/M Intracranial injury Sputum 2019 Jan
KP3295 52/M Paraplegia Urine 2018 Aug
 

Main Article

Page created: September 05, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external